Li Ning

Health Trends And E-Commerce Will Expand Premium Markets

AnalystHighTarget

Not Invested

Consensus Narrative from 30 Analysts

Published

26 Jun 25

AnalystHighTarget's Fair Value

HK$33.31

44.2% undervalued

27 Aug

HK$18.59

30.7%

-1.2%

30.7%

-1.2%

Edit anytime before Jun 26 9:21 PM. Then post Updates to your followers.

Author's Valuation

HK$33.3

44.2% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

HK$33.3

44.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.16%

Luxury revenue growth rate

0.31%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.76%

Calculation

CN¥3.89b

Earnings '28

26.14x

PE Ratio '28

CN¥101.69b

Market Cap '28

CN¥101.69b

Market Cap '28

2.58b

No. shares '28

CN¥39.41

Share Price '28

CN¥39.41 Share Price '28

Discounted to 2025 @ 8.75% p.a.

CN¥30.64

Fair Value '25

CN¥30.64 Fair Value '25

Converted to HKD @ 1.0867 CNY/HKD Exchange Rate

HK$33.30

Fair Value '25